Replacing Lu-177 with Tb-161 in DOTA-TATE and PSMA-617 therapy: potential dosimetric implications for activity selection.

Authors:
Verburg FA; de Blois E; Koolen S; Konijnenberg MW.

Journal:
EJNMMI Phys

Publication Year: 2023

DOI:
10.1186/s40658-023-00589-w

PMCID:
PMC10638215

PMID:
37947917

View on PubMed View on PMC View Publisher
Journal Information

Full Title: EJNMMI Phys

Abbreviation: EJNMMI Phys

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Radiology, Nuclear Medicine & Medical Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
3D printed non-uniform anthropomorphic phantoms for quantitative SPECT.
Jessen L; Gustafsson J; Ljungberg M and 3 more (2024) - Transparency Score: 3/6
Biodistribution and radiation dosimetry of <sup>124</sup>I-mIBG in adult patients with neural crest…
Moraitis A; Jentzen W; Reiter G and 8 more (2024) - Transparency Score: 3/6
Clinical feasibility study of early 30-minute dynamic FDG-PET scanning protocol for patients with l…
Du F; Wumener X; Zhang Y and 10 more (2024) - Transparency Score: 3/6
Feasibility of <sup>177</sup>Lu activity quantification using a small portable CZT-based gamma-came…
Roth D; Larsson E; Strand J and 2 more (2024) - Transparency Score: 3/6
Feasibility study of a SiPM-fiber detector for non-invasive measurement of arterial input function …
de Scals S; Fraile LM; Udías JM and 6 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding The authors declare that no funds, grants or other support were received during the preparation of this manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025